SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (13329)10/6/2004 2:54:13 AM
From: Icebrg  Read Replies (1) | Respond to of 52153
 
[CTIC] >>As I have stated before, I consider the current market as a whole to be rather uninspiring, and so I view opportunities like this, where one can make 20% in under 6 months in a stagnant stock to be quite attractive.>>

Sam,

the reason for the high premium is the expected release of Xyotax Stellar 3 data early next year. That will be a truly binary event. Especially on the upside. The downside seems better protected as the current valuation appears to be "supported" by Pixantrone and to certain degree also by Trisenox.

Erik



To: Sam Citron who wrote (13329)10/6/2004 6:56:43 AM
From: tom pope  Respond to of 52153
 
I didn't do it in my head, Sam, believe me <g>. Schwab Trader CT has a useful function that provides the implied volatilities.



To: Sam Citron who wrote (13329)10/6/2004 9:26:42 AM
From: tuck  Read Replies (1) | Respond to of 52153
 
For those without Schwab accounts there are a couple of others sources for calculation of implied volatility. One is here:

cboe.com

Another is Peter.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News